Rapid susceptibility testing of Candida albicans by flow cytometry

Journal of Clinical Microbiology

Volumn 35, Issue 2, 1997, Pages 358-363

  Kirk, Scott M ^a,b   Callister, Steven M ^c   Lim, Lony C L ^a,b   Schell, Ronald F ^a,b  

^a WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c GUNDERSEN LUTHERAN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; ITRACONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; FLOW CYTOMETRY; FUNGUS CULTURE; FUNGUS GROWTH; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; PRIORITY JOURNAL;

EID: 0031020012     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.35.2.358-363.1997     Document Type: Article

References (39)

1. Bownds, S. E., T. A. Kurzynski, M. A. Norden, J. L. DuFek, and R. F. Schell. 1996. Rapid susceptibility testing for nontuberculosis mycobacteria using flow cytometry. J. Clin. Microbiol. 34:1386-1390.
2. Boye, E., H. B. Steen, and K. Skarstad. 1983. Flow cytometry of bacteria: a promising tool in experimental and clinical microbiology. J. Gen. Microbiol 129:973-980.
3. Darzynkiewicz, Z., and J. Kapuscinski. 1990. Acridine orange: a versatile probe of nucleic acids and other cell constituents, p. 291-314. In M. A. Melamed, T. Lindmo, and M. L. Mendelsohn (ed.), Flow cytometry and sorting, 2nd ed. Wiley-Liss, Inc., New York, N.Y.
4. Dick, J. D., W. G. Merz, and R. Saral. 1980. Incidence of polyene-resistant yeasts recovered from clinical specimens. Antimicrob. Agents Chemother. 18:158-163.
5. Diamond, R. D. 1991. The growing problem of mycoses in patients with the human immunodeficiency virus. Rev. Infect. Dis. 13:480-486.
6. Diaper, J. P., K. Tither, and C. Edwards. 1992. Rapid assessment of bacterial viability by flow cytometry. Appl. Microbiol. Biotechnol. 38:268-272.
7. Espinel-Ingroff, A., M. Pfaller, M. E. Erwin, and R. N. Jones. 1996. An interlaboratory evaluation of E-test method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J. Clin. Microbiol. 34:848-852.
8. Espinel-Ingroff, A., J. L. Rodrigues-Tudela, and J. V. Martinez-Suarez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing of fluconazole-resistant and -susceptible isolates of Candida albicans. J. Clin. Microbiol. 33:3154-3158.
9. Fromtling, R. A., J. N. Galgiani, M. A. Pfaller, A. Espinel-Ingroff, K. F. Bartizal, M. S. Bartlett, B. A. Body, C. Frey, G. Hall, G. D. Roberts, F. B. Nolte, F. C. Odds, M. G. Rinaldi, A. M. Sugar, and K. Villareal. 1993. Multicenter evaluation of a macrobroth antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37:39-45.
10. Gant, V. A., G. Warnes, I. Phillips, and G. F. Savidge. 1993. The application of flow cytometry to the study of bacterial responses to antibiotics. J. Med. Microbiol. 39:147-154.
11. Georgopapadakou, N. H., and J. S. Tkacz. 1995. The fungal cell wall as a drug target. Trends Microbiol. 3:98-104.
12. Ghannoum, M. A., J. H. Rex, and J. N. Galgiani. 1996. Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome. J. Clin. Microbiol. 34:489-495.
13. Green, L., B. Petersen, L. Steimel, P. Haeber, and W. Current. 1994. Rapid determination of antifungal activity by flow cytometry. J. Clin. Microbiol. 32:1088-1091.
14. Guinet, R., J. Chanas, A. Goullier, G. Bonnefoy, and P. Ambroise-Thomas. 1983. Fatal septicemia due to amphotericin B-resistant Candida lusitaniae. J. Clin. Microbiol. 18:443-444.
15. Jernaes, M. W., and H. B. Steen. 1994. Staining of Escherichia coli for flow cytometry: influx and efflux of ethidium bromide. Cytometry 17:302-309.
16. Kaprelyants, A. S., and D. B. Kell. 1992. Rapid assessment of bacterial viability and vitality by rhodamine 123 and flow cytometry. J. Appl. Bacteriol. 72:410-422.
17. Lim, L. C. L., Y. F. Liu, K. Schell, S. D. Lovrich, S. M. Callister, and R. F. Schell. 1994. Detection of borreliacidal antibody by using acridine orange and flow cytometry. Clin. Diagn. Lab. Immunol. 1:44-50.
18. Mason, D. J., R. Allman, J. M. Stark, and D. Lloyd. 1994. Rapid estimation of bacterial antibiotic susceptibility with flow cytometry. J. Microsc. 176:8-16.
19. Mason, D. J., and V. A. Gant. 1995. Correspondence. J. Antimicrob. Chemother. 36:441-443.
20. Mason, D. J., R. Lopez-Amoros, R. Allman, J. M. Stark, and D. Lloyd. 1995. The ability of membrane potential dyes and calcafluor white to distinguish between viable and non-viable bacteria. J. Appl. Bacteriol. 78:309-315.
21. Merz, W. G. 1984. Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. J. Clin. Microbiol. 20:1194-1195.
22. National Committee for Clinical Laboratory Standards. 1992. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. NCCLS documant M27-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. Norden, M. A., T. A. Kurzynski, S. E. Bownds, S. M. Callister, and R. F. Schell. 1995. Rapid susceptibility testing of Mycobacterium tuberculosis (H37Ra) by flow cytometry. J. Clin. Microbiol. 33:1231-1237.
24. O'Gorman, M. R. G., and R. L. Hopfer. 1991. Amphotericin B susceptibility testing of Candida species by flow cytometry. Cytometry 12:743-747.
25. Ordonez, J. V., and N. M. Wehman. 1993. Rapid flow cytometric antibiotic susceptibility assay for Staphylococcus aureus. Cytometry 14:811-818.
26. Polak, A., and P. G. Hartman. 1991. Antifungal chemotherapy - are we winning? Prog. Drug Res. 37:181-269.
27. Pore, R. S. 1994. Antibiotic susceptibility testing by flow cytometry. J. Antimicrob. Chemother. 34:613-627.
28. Pore, R. S. 1992. Amphotericin B synergy testing by the FCST. Curr. Microbiol. 24:171-177.
29. Pore, R. S. 1991. Ketoconazole susceptibility of yeasts by the FCST method. Curr. Microbiol. 23:45-50.
30. Pore, R. S. 1990. Antibiotic susceptibility testing of Candida albicans by flow cytometry. Curr. Microbiol. 20:323-328.
31. Rex, J. H., M. A. Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993. Antifungal susceptibility testing. Clin. Microbiol. Rev. 6:367-381.
32. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
33. Scholer, H. 1980. Antifungal chemotherapy, p. 35-106. In D. C. E. Speller. (ed.). John Wiley & Sons, Inc., New York, N.Y.
34. Shapiro, H. M. 1990. Flow cytometry in laboratory microbiology: new directions. ASM News 56:584-588.
35. Steen, H. B., K. Skarstad, and E. Boye. 1986. Flow cytometry of bacteria: cell cycle kinetics and effects of antibiotics. Ann. N. Y. Acad. Sci. 486:329-338.
36. To, W-K, A. W. Fothergill, and M. G. Rinaldi. 1995. Comparative evaluation of macrodilution and Alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates. J. Clin. Microbiol. 33:2660-2664.
37. Vanden Bossche, H., P. Marichal, and F. C. Odds. 1994. Molecular mechanisms of drug resistance in fungi. Trends Microbiol. 2:393-400.
38. Vanden Bossche, H., G. Willemsens, and P. Marichal. 1987. Anti-Candida drugs - the biochemical basis for their activity. Crit. Rev. Microbiol. 15:57-72.
39. Van Eldere, J., L. Joosten, A. Verhaeghe, and I. Surmont. 1996. Fluconazole and amphotericin B antifungal susceptibility testing by National Committee for Clinical Laboratory Standards broth macrodilution method compared with E-test and semiautomated broth microdilution test. J. Clin. Microbiol. 34:842-847.